Deregulated expression of the c-myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-gamma, heparin, and cyclic nucleotide analogues and induces apoptosis.
- 1 March 1994
- journal article
- abstracts
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 74 (3), 525-536
- https://doi.org/10.1161/01.res.74.3.525
Abstract
We have investigated the requirement for c-myc downregulation in the growth arrest of vascular smooth muscle cells (VSMCs). Rat VSMCs were infected with a retrovirus vector directing constitutive expression of either the complete human c-Myc protein (VSM-myc cells) or the c-Myc deletion mutant D106-143, which is inactive in cotransformation and autosuppression assays (VSM-D106-143 myc cells). Clones of transfected VSM-myc cells were isolated that constitutively expressed a range of levels of c-Myc protein from that observed in normal proliferating VSMCs to approximately seven times normal. The growth rates of these clones and their responses to growth inhibitors were then assessed. VSM-myc clones possessed a shorter mean intermitotic time than normal cells, which was inversely correlated (P < .05) with the level of c-Myc protein expressed. VSM-myc cells also expressed lower levels of alpha-smooth muscle actin mRNA and protein and exhibited an altered morphology. The proliferation of normal VSMCs and VSM-D106-143 myc cells was inhibited by serum reduction (0.5% fetal calf serum) and also by treatment with interferon-gamma (100 IU/mL), heparin (50 micrograms/mL), 8-bromo-cAMP (0.1 mmol/L), or 8-bromo-cGMP (0.1 mmol/L). In contrast, proliferation of VSM-myc cells was not inhibited by any of these agents, even if present at 10-fold higher concentrations. However, approximately 75% of VSM-myc cells expressing levels of c-Myc protein seen in normal proliferating VSMCs underwent apoptosis after 4 days of serum reduction or treatment with interferon-gamma. The results show that constitutive c-myc expression induces continuous cell proliferation, reduction in alpha-smooth muscle actin expression and apoptosis in VSMCs. We conclude that downregulation of c-myc is a prerequisite for growth arrest and subsequent survival of VSMCs. Conversely, deregulated c-myc expression may be important in the proliferation and death of VSMCs--characteristics of the pathogenesis of atherosclerosis.Keywords
This publication has 47 references indexed in Scilit:
- The role of c-myc in cell growthCurrent Opinion in Genetics & Development, 1993
- Myc and Max proteins possess distinct transcriptional activitiesNature, 1992
- Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overviewCancer and Metastasis Reviews, 1992
- Role for c-myc in Activation-Induced Apoptotic Cell Death in T Cell HybridomasScience, 1992
- Induction of apoptosis in fibroblasts by c-myc proteinCell, 1992
- Cell cycle dependent gene expression in quiescent stimulated and asynchronously cycling arterial smooth muscle cells in cultureJournal of Cellular Physiology, 1992
- Induction of cell cycle‐dependent genes during cell cycle progression of arterial smooth muscle cells in cultureJournal of Cellular Physiology, 1991
- A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1Nature, 1987
- Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiationNature, 1986
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979